Effects of udenafil and tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms undergoing transurethral resection of the prostate

Trial Profile

Effects of udenafil and tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms undergoing transurethral resection of the prostate

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2011

At a glance

  • Drugs Tadalafil; Udenafil
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 16 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top